HIV-1 persistence in CD4+ T cells with stem cell–like properties MJ Buzon, H Sun, C Li, A Shaw, K Seiss, Z Ouyang, E Martin-Gayo, ... Nature Medicine 20, 139-142, 2014 | 484 | 2014 |
Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells MJ Buzon, E Martin-Gayo, F Pereyra, Z Ouyang, H Sun, JZ Li, M Piovoso, ... Journal of virology 88 (17), 10056-10065, 2014 | 314 | 2014 |
A model predictive control based scheduling method for HIV therapy R Zurakowski, AR Teel Journal of Theoretical Biology 238 (2), 368-382, 2006 | 195 | 2006 |
The Tobit Kalman Filter: An Estimator for Censored Measurements B Allik, C Miller, MJ Piovoso, R Zurakowski IEEE Transactions on Control Systems Technology, 10.1109/TCST.2015.2432155, 2015 | 97 | 2015 |
HIV Model Parameter Estimates from Interruption Trial Data including Drug Efficacy and Reservoir Dynamics R Luo, MJ Piovoso, J Martinez-Picado, R Zurakowski PLoS One 7 (7), e40198, 2012 | 90 | 2012 |
Enhancing immune response to HIV infection using MPC-based treatment scheduling R Zurakowski, AR Teel Proceedings of the American Control Conference 2, 1182-1187, 2003 | 55 | 2003 |
Nonlinear estimators for censored data: A comparison of the EKF, the UKF and the Tobit Kalman filter B Allik, C Miller, MJ Piovoso, R Zurakowski 2015 American Control Conference (ACC), 5146-5151, 2015 | 51 | 2015 |
Persistence of an intact HIV reservoir in phenotypically naive T cells EV Rullo, MR Pinzone, LM Cannon, S Weissman, M Ceccarelli, ... JCI insight 5 (20), 2020 | 47 | 2020 |
Modelling HIV-1 2-LTR dynamics following raltegravir intensification R Luo, EF Cardozo, MJ Piovoso, H Wu, MJ Buzon, J Martinez-Picado, ... J. R. Soc. Interface 10 (84), 20130186, 2013 | 46 | 2013 |
Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence J Martinez-Picado, R Zurakowski, MJ Buzón, M Stevenson Retrovirology 15, 1-11, 2018 | 38 | 2018 |
Model-driven approaches for in vitro combination therapy using ONYX-015 replicating oncolytic adenovirus R Zurakowski, D Wodarz Journal of theoretical biology 245 (1), 1-8, 2007 | 38 | 2007 |
Optimal antiviral switching to minimize resistance risk in HIV therapy R Luo, MJ Piovoso, J Martinez-Picado, R Zurakowski PloS one 6 (11), e27047, 2011 | 37 | 2011 |
Estimation of Saturated Data Using the Tobit Kalman Filter B Allik, C Miller, MJ Piovoso, R Zurakowski American Control Conference (ACC), 2014, 4151-4156, 2014 | 34 | 2014 |
Nonlinear observer output-feedback MPC treatment scheduling for HIV R Zurakowski Biomedical engineering online 10 (1), 40, 2011 | 34* | 2011 |
Spatial modeling of HIV cryptic viremia and 2-LTR formation during raltegravir intensification EF Cardozo, R Luo, MJ Piovoso, R Zurakowski Journal of theoretical biology 345, 61-69, 2014 | 32* | 2014 |
Ballistic Roll Estimation Using EKF Frequency Tracking and Adaptive Noise Cancellation B Allik, M Ilg, R Zurakowski IEEE Transactions on Aerospace and Electronic Systems 49 (4), 2546-2553, 2013 | 28 | 2013 |
Treatment scheduling for HIV using robust nonlinear model predictive control R Zurakowski, MJ Messina, SE Tuna, AR Teel Australian Journal of Electrical & Electronics Engineering 2 (1), 49, 2005 | 27* | 2005 |
Controlling the evolution of resistance R Luo, LM Cannon, J Hernandez, MJ Piovoso, R Zurakowski Journal of Process Control 21 (3), 367-378, 2011 | 24 | 2011 |
Utilizing alternate target cells in treating HIV infection through scheduled treatment R Zurakowski, AR Teel, D Wodarz American Control Conference (ACC), 2004, 1, 946-951, 2004 | 22 | 2004 |
Modeling Uncertainty in Single-Copy Assays for HIV. R Luo, MJ Piovoso, R Zurakowski J. Clin. Microbiol. 50 (10), 3382-3383, 2012 | 20 | 2012 |